Literature DB >> 15650197

Regulation of expression of the Epstein-Barr virus BamHI-A rightward transcripts.

Honglin Chen1, Jian Huang, Frederick Y Wu, Gangling Liao, Lindsey Hutt-Fletcher, S Diane Hayward.   

Abstract

The Epstein-Barr virus (EBV) BamHI-A rightward transcripts, or BARTs, are a family of mRNAs expressed in all EBV latency programs, including EBV-infected B cells in healthy carriers. Despite their ubiquitous expression, the regulation and biological function of BARTs are still unclear. In this study, the BART 5' termini were characterized by using a procedure that selects capped, full-length mRNAs. Two TATA-less promoter regions, designated P1 and P2, were mapped. P1 had relatively high basal activity in both epithelial and B cells, whereas P2 exhibited higher activity in epithelial cells. Upon EBV infection of B cells, transcription from P1 was detected soon after infection, while expression from P2 was delayed. Promoter-reporter assays in transiently transfected cells revealed that P1 and P2 were differentially regulated. Interferon regulatory factor 7 (IRF7) and IRF5 negatively regulated P1 activity. c-Myc and C/EBP family members positively regulated P2. Regulation of P2 by C/EBPs was characterized by electrophoretic mobility shift assay, chromatin immunoprecipitation, and reporter assays. More-abundant BART expression in epithelial cells correlated with the relative expression of positive and negative regulators in these cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15650197      PMCID: PMC544122          DOI: 10.1128/JVI.79.3.1724-1733.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  76 in total

1.  Updated Epstein-Barr virus (EBV) DNA sequence and analysis of a promoter for the BART (CST, BARF0) RNAs of EBV.

Authors:  Orlando de Jesus; Paul R Smith; Lindsay C Spender; Claudio Elgueta Karstegl; Hans Helmut Niller; Dolly Huang; Paul J Farrell
Journal:  J Gen Virol       Date:  2003-06       Impact factor: 3.891

2.  In vivo transcription of the Epstein-Barr virus (EBV) BamHI-A region without associated in vivo BARF0 protein expression in multiple EBV-associated disorders.

Authors:  Josine van Beek; Antoinette A T P Brink; Marcel B H J Vervoort; Mireille J M van Zijp; Chris J L M Meijer; Adriaan J C van den Brule; Jaap M Middeldorp
Journal:  J Gen Virol       Date:  2003-10       Impact factor: 3.891

3.  RACK1 is a functional target of the E1A oncoprotein.

Authors:  Anna Severino; Alfonso Baldi; Giuliano Cottone; Mei Han; Nianli Sang; Antonio Giordano; Anna Maria Mileo; Marco G Paggi; Antonio De Luca
Journal:  J Cell Physiol       Date:  2004-04       Impact factor: 6.384

4.  Virus-induced heterodimer formation between IRF-5 and IRF-7 modulates assembly of the IFNA enhanceosome in vivo and transcriptional activity of IFNA genes.

Authors:  Betsy J Barnes; Ann E Field; Paula M Pitha-Rowe
Journal:  J Biol Chem       Date:  2003-02-24       Impact factor: 5.157

5.  Interferon regulatory factor 5, a novel mediator of cell cycle arrest and cell death.

Authors:  Betsy J Barnes; Merrill J Kellum; Karen E Pinder; J Augusto Frisancho; Paula M Pitha
Journal:  Cancer Res       Date:  2003-10-01       Impact factor: 12.701

6.  CCAAT/enhancer binding protein alpha binds to the Epstein-Barr virus (EBV) ZTA protein through oligomeric interactions and contributes to cooperative transcriptional activation of the ZTA promoter through direct binding to the ZII and ZIIIB motifs during induction of the EBV lytic cycle.

Authors:  Frederick Y Wu; Shizhen Emily Wang; Honglin Chen; Ling Wang; S Diane Hayward; Gary S Hayward
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

7.  The WD motif-containing protein RACK-1 functions as a scaffold protein within the type I IFN receptor-signaling complex.

Authors:  Anna Usacheva; Xinyong Tian; Raudel Sandoval; Debra Salvi; David Levy; Oscar R Colamonici
Journal:  J Immunol       Date:  2003-09-15       Impact factor: 5.422

8.  A positive autoregulatory loop of LMP1 expression and STAT activation in epithelial cells latently infected with Epstein-Barr virus.

Authors:  Honglin Chen; Lindsey Hutt-Fletcher; Liang Cao; S Diane Hayward
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

Review 9.  Stealth technology: how Epstein-Barr virus utilizes DNA methylation to cloak itself from immune detection.

Authors:  Qian Tao; Keith D Robertson
Journal:  Clin Immunol       Date:  2003-10       Impact factor: 3.969

Review 10.  Host cell-dependent expression of latent Epstein-Barr virus genomes: regulation by DNA methylation.

Authors:  Hul Li; Janos Minarovits
Journal:  Adv Cancer Res       Date:  2003       Impact factor: 6.242

View more
  40 in total

Review 1.  EBV Noncoding RNAs.

Authors:  Rebecca L Skalsky; Bryan R Cullen
Journal:  Curr Top Microbiol Immunol       Date:  2015       Impact factor: 4.291

Review 2.  IRF7: activation, regulation, modification and function.

Authors:  S Ning; J S Pagano; G N Barber
Journal:  Genes Immun       Date:  2011-04-14       Impact factor: 2.676

3.  A combined computational and microarray-based approach identifies novel microRNAs encoded by human gamma-herpesviruses.

Authors:  Adam Grundhoff; Christopher S Sullivan; Don Ganem
Journal:  RNA       Date:  2006-03-15       Impact factor: 4.942

4.  Epstein-Barr virus BHRF1 micro- and stable RNAs during latency III and after induction of replication.

Authors:  Li Xing; Elliott Kieff
Journal:  J Virol       Date:  2007-07-11       Impact factor: 5.103

5.  Changes in chemokines and chemokine receptor expression on tonsillar B cells upon Epstein-Barr virus infection.

Authors:  Barbro Ehlin-Henriksson; Wu Liang; Alberto Cagigi; Frida Mowafi; George Klein; Anna Nilsson
Journal:  Immunology       Date:  2009-08       Impact factor: 7.397

6.  The role of promoter methylation in Epstein-Barr virus (EBV) microRNA expression in EBV-infected B cell lines.

Authors:  Do Nyun Kim; Yoon Jae Song; Suk Kyeong Lee
Journal:  Exp Mol Med       Date:  2011-07-30       Impact factor: 8.718

7.  The A20 deubiquitinase activity negatively regulates LMP1 activation of IRF7.

Authors:  Shunbin Ning; Joseph S Pagano
Journal:  J Virol       Date:  2010-04-14       Impact factor: 5.103

Review 8.  The role of Epstein-Barr virus infection in the pathogenesis of nasopharyngeal carcinoma.

Authors:  Chi Man Tsang; Sai Wah Tsao
Journal:  Virol Sin       Date:  2015-04-21       Impact factor: 4.327

9.  A Genome-Wide Epstein-Barr Virus Polyadenylation Map and Its Antisense RNA to EBNA.

Authors:  Vladimir Majerciak; Wenjing Yang; Jing Zheng; Jun Zhu; Zhi-Ming Zheng
Journal:  J Virol       Date:  2019-01-04       Impact factor: 5.103

10.  Expression and processing of a small nucleolar RNA from the Epstein-Barr virus genome.

Authors:  Roland Hutzinger; Regina Feederle; Jan Mrazek; Natalia Schiefermeier; Piotr J Balwierz; Mihaela Zavolan; Norbert Polacek; Henri-Jacques Delecluse; Alexander Hüttenhofer
Journal:  PLoS Pathog       Date:  2009-08-14       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.